Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ALGN
stocks logo

ALGN

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.03B
+3.68%
2.963
+21.43%
1.01B
+3.52%
2.408
+13.05%
1.05B
+4.03%
2.682
+7.72%
Estimates Revision
The market is revising Upward the revenue expectations for Align Technology, Inc. (ALGN) for FY2025, with the revenue forecasts being adjusted by 0.24% over the past three months. During the same period, the stock price has changed by 12.74%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.24%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.87%
In Past 3 Month
Stock Price
Go Up
up Image
+12.74%
In Past 3 Month
Wall Street analysts forecast ALGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALGN is 171.33 USD with a low forecast of 140.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast ALGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALGN is 171.33 USD with a low forecast of 140.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 156.840
sliders
Low
140.00
Averages
171.33
High
200.00
Current: 156.840
sliders
Low
140.00
Averages
171.33
High
200.00
Evercore ISI
Outperform
maintain
$160 -> $170
2025-10-30
Reason
Evercore ISI
Price Target
$160 -> $170
2025-10-30
maintain
Outperform
Reason
Evercore ISI raised the firm's price target on Align Technology to $170 from $160 and keeps an Outperform rating on the shares after "a strong Q3 performance" with cases up 4.9% year-over-year, topping expectations. A 22c beat on EPS "underlines the effective cost management and operational leverage," the analyst tells investors.
Piper Sandler
Jason Bednar
Overweight
maintain
$190 -> $200
2025-10-30
Reason
Piper Sandler
Jason Bednar
Price Target
$190 -> $200
2025-10-30
maintain
Overweight
Reason
Piper Sandler analyst Jason Bednar raised the firm's price target on Align Technology to $200 from $190 and keeps an Overweight rating on the shares. Shares of Align have been out-of-favor with investors since the Q2 print, in part because of revenue visibility challenges the business had encountered, but also due to an implied Q4 revenue ramp that looked challenging based on historical seasonality, the firm notes. But Q3 cured both of those ills as management delivered broad volume upside in the period, which has the effect of also shortening the putt to hit the originally implied Q4 targets, adds Piper.
UBS
Neutral
downgrade
$160 -> $155
2025-10-16
Reason
UBS
Price Target
$160 -> $155
2025-10-16
downgrade
Neutral
Reason
UBS lowered the firm's price target on Align Technology to $155 from $160 and keeps a Neutral rating on the shares. Shares are down 38% year-to-date and 81% from 2021 highs, trading at a historically low multiple after a weak Q2, the analyst tells investors in a research note. Sentiment remains pressured by share losses to traditional braces and competitors, declining ASPs for Invisalign, soft consumer confidence, limited management visibility, and muted dental demand, factors that have eroded confidence in Align's ability to meet Q3 expectations or maintain full-year guidance, the firm says.
Leerink
Outperform
maintain
$246 -> $248
2025-07-14
Reason
Leerink
Price Target
$246 -> $248
2025-07-14
maintain
Outperform
Reason
Leerink raised the firm's price target on Align Technology to $248 from $246 and keeps an Outperform rating on the shares. Heading into Q2 earnings, the firm is updating dental company estimates and publishing the results of its fourth semi-annual dental survey of 63 dental practitioners in the United States. There is clearly a budding interest in identifying incremental improvements across the dental space, even if each opportunity seems to be company-specific in what remains a still-challenged total dental end-market, Leerink says. The firm sees reasons to be positive on each stock in its coverage but also has some offsetting questions that limit too much constructiveness.
HSBC
Buy
to
Hold
downgrade
$290 -> $170
2025-04-25
Reason
HSBC
Price Target
$290 -> $170
2025-04-25
downgrade
Buy
to
Hold
Reason
HSBC downgraded Align Technology to Hold from Buy with a price target of $170, down from $290. The firm adjusted ratings in medical technology and life sciences are quantifying the risk/reward using stagflation, weak macro environment, and recovery scenario analyses. The market is debating whether the recent multiples correction is an opportunity to buy, or if it is the start of a potential recession, the analyst tells investors in a research note. HSBC's analysis of historical sector multiples reveals that the multiples compression might have an additional 20%-25% downside in a stagflation scenario. "We are far from the point where one can argue that these stocks are pricing in a recession," contends HSBC.
UBS
Neutral
downgrade
$240 -> $215
2025-04-24
Reason
UBS
Price Target
$240 -> $215
2025-04-24
downgrade
Neutral
Reason
UBS lowered the firm's price target on Align Technology to $215 from $240 and keeps a Neutral rating on the shares. While macro concerns are weighing on the stock, increased financing options may drive upside, the analyst tells investors in a research note. The company's May 6 investor day presents a catalyst for the management team to reshape the narrative, set a new, and more realistic, long-term target, and detail the contribution and market opportunity for new offerings, UBS says.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Align Technology Inc (ALGN.O) is 14.53, compared to its 5-year average forward P/E of 34.38. For a more detailed relative valuation and DCF analysis to assess Align Technology Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
34.38
Current PE
14.53
Overvalued PE
50.00
Undervalued PE
18.77

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
23.07
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
33.51
Undervalued EV/EBITDA
12.63

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.42
Current PS
0.00
Overvalued PS
9.65
Undervalued PS
3.19
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ALGN News & Events

Events Timeline

(ET)
2025-11-24
20:13:45
Align Technology announces that Invisalign is now commercially available in the Philippines.
select
2025-10-30 (ET)
2025-10-30
09:55:03
Significant Early Gainers in Liquid Options on October 30th
select
2025-10-29 (ET)
2025-10-29
16:03:57
Align Technology announces Q3 adjusted EPS of $2.61, surpassing consensus estimate of $2.41.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.5
11-26Newsfilter
Align Technology Achieves Multiple Top Rankings in 2025 Investor Relations Awards
  • Leadership Recognition: Align Technology achieved multiple #1, #3, and top 10 rankings in the 2025 Extel survey, showcasing its exceptional leadership and investor relations performance in the Health Care Technology & Distribution sector, thereby reinforcing its market position.
  • Ongoing Excellence: This marks the third recognition for Align by Extel in four years, reflecting the company's commitment to transparent communication and investor relations, which enhances investor trust and competitive edge in the market.
  • Outstanding Executive Performance: CEO Joseph Hogan and CFO John Morici ranked #1 in the Large-Cap category, further demonstrating the leadership and influence of Align's executive team within the industry.
  • Best Investor Events: Align's investor/analyst events secured the #1 position in both the Large-Cap and Health Care Technology & Distribution categories, indicating its exceptional performance in investor communication and engagement, thus enhancing the company's image among investors.
[object Object]
Preview
5.0
11-25Newsfilter
Align Technology Launches New Invisalign System for Class II Malocclusion in Kids, Enhancing Treatment Efficiency
  • Innovative Treatment Solution: Align Technology's newly launched Invisalign System in the Philippines integrates mandibular advancement with occlusal blocks specifically designed for children and teenagers, effectively addressing Class II skeletal discrepancies that account for approximately 30-45% of malocclusions globally, thereby enhancing treatment efficiency.
  • Market Expansion: The system is now commercially available in multiple countries including Australia, New Zealand, Japan, and Hong Kong, marking Align's strategic expansion in the Asia-Pacific region, which is expected to attract more young patients seeking efficient correction solutions.
  • Enhanced Patient Experience: The new occlusal blocks are made from patented SmartTrack™ material, providing increased comfort and compliance, as studies indicate that patient comfort directly influences wear time, thereby improving treatment outcomes.
  • Significant Clinical Outcomes: Clinical data shows that treatment results with this system are on par with traditional Clark Twin Blocks, and the design of the occlusal blocks virtually eliminates crushing issues during treatment, ensuring a smooth progression for patients.
[object Object]
Preview
4.5
11-18NASDAQ.COM
Stocks Decline Before Nvidia Earnings Report and US Economic Indicators

  • US Stock Market Performance: The S&P 500, Dow Jones, and Nasdaq all experienced declines on Monday, with the S&P 500 falling by 0.92%. The market is anticipating key economic reports and Nvidia's earnings later this week, while Alphabet's stock rose by 3% following Berkshire Hathaway's investment.

  • Economic Reports and Fed Outlook: A heavy schedule of delayed US economic reports is set for release this week, including employment data and manufacturing indices. The market is pricing in a 41% chance of a rate cut at the upcoming FOMC meeting, supported by Fed Governor Waller's comments on the labor market.

  • Corporate Earnings Trends: Q3 earnings season is nearing completion, with 82% of S&P 500 companies exceeding forecasts, leading to a 14.6% increase in earnings, significantly above expectations. Notable stock movements include Alphabet's rise and declines in major tech stocks like Nvidia and Apple.

  • International Market Movements: Overseas markets closed lower, with the Euro Stoxx 50 down 0.93% and declines in China's Shanghai Composite and Japan's Nikkei. European bond yields fell, while the European Commission raised its GDP forecast for the Eurozone, indicating a mixed outlook for economic stability.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Align Technology Inc (ALGN) stock price today?

The current price of ALGN is 156.84 USD — it has increased 1.19 % in the last trading day.

arrow icon

What is Align Technology Inc (ALGN)'s business?

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

arrow icon

What is the price predicton of ALGN Stock?

Wall Street analysts forecast ALGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALGN is 171.33 USD with a low forecast of 140.00 USD and a high forecast of 200.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Align Technology Inc (ALGN)'s revenue for the last quarter?

Align Technology Inc revenue for the last quarter amounts to 995.69M USD, increased 1.82 % YoY.

arrow icon

What is Align Technology Inc (ALGN)'s earnings per share (EPS) for the last quarter?

Align Technology Inc. EPS for the last quarter amounts to 0.78 USD, decreased -49.68 % YoY.

arrow icon

What changes have occurred in the market's expectations for Align Technology Inc (ALGN)'s fundamentals?

The market is revising Upward the revenue expectations for Align Technology, Inc. (ALGN) for FY2025, with the revenue forecasts being adjusted by 0.24% over the past three months. During the same period, the stock price has changed by 12.74%.
arrow icon

How many employees does Align Technology Inc (ALGN). have?

Align Technology Inc (ALGN) has 20945 emplpoyees as of December 05 2025.

arrow icon

What is Align Technology Inc (ALGN) market cap?

Today ALGN has the market capitalization of 11.25B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free